Eric R Olson - Net Worth and Insider Trading

Eric R Olson Net Worth

The estimated net worth of Eric R Olson is at least $35,770 dollars as of 2024-04-29. Eric R Olson is the Chief Scientific Officer of Syros Pharmaceuticals Inc and owns about 6,661 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $35,770. Details can be seen in Eric R Olson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric R Olson has not made any transactions after 2023-07-17 and currently still holds the listed stock(s).

Transaction Summary of Eric R Olson

To

Eric R Olson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric R Olson owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .

Click here to see the complete history of Eric R Olson’s form 4 insider trades.

Insider Ownership Summary of Eric R Olson

Ticker Comapny Transaction Date Type of Owner
SYRS Syros Pharmaceuticals Inc 2023-07-17 Chief Scientific Officer

Eric R Olson Latest Holdings Summary

Eric R Olson currently owns a total of 1 stock. Eric R Olson owns 6,661 shares of Syros Pharmaceuticals Inc (SYRS) as of July 17, 2023, with a value of $35,770.

Latest Holdings of Eric R Olson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SYRS Syros Pharmaceuticals Inc 2023-07-17 6,661 5.37 35,770

Holding Weightings of Eric R Olson


Eric R Olson Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric R Olson has made a total of 5 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 689 shares on July 17, 2023, which brought Eric R Olson around $2,412.

Insider Trading History of Eric R Olson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric R Olson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eric R Olson Ownership Network

Ownership Network List of Eric R Olson

No Data

Ownership Network Relation of Eric R Olson


Eric R Olson Owned Company Details

What does Syros Pharmaceuticals Inc do?

Who are the key executives at Syros Pharmaceuticals Inc?

Eric R Olson is the Chief Scientific Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Medical Officer David Roth , Chief Financial Officer Jason Haas , and Chief Commercial Officer Chee Conley .

Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary

Over the past 18 months, Eric R Olson made 1 insider transaction in Syros Pharmaceuticals Inc (SYRS) with a net sale of 689. Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju ,

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Syros Pharmaceuticals Inc Insider Transactions

No Available Data

Eric R Olson Mailing Address

Above is the net worth, insider trading, and ownership report for Eric R Olson. You might contact Eric R Olson via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive, Suite 300, Cambridge Ma 02139.

Discussions on Eric R Olson

No discussions yet.